Feedback (GB:FDBK) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Feedback PLC, a clinical infrastructure specialist, has received additional funding to continue its Community Diagnostic Centre (CDC) pathway pilot at the Northern Care Alliance NHS Foundation Trust, demonstrating promising results in reducing patient wait times and improving diagnostic processes. The company’s digital referral system, Bleepa®, has significantly expanded, now supporting more specialties and users, leading to substantial time savings and potential cost reductions for the NHS. These developments underscore Feedback’s commitment to enhancing healthcare efficiency and the scalability of its technology in public and private healthcare markets.
For further insights into GB:FDBK stock, check out TipRanks’ Stock Analysis page.
